Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report published on Sunday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $7.47. The company has a market capitalization of $2,497.00, a P/E ratio of 0.00 and a beta of 2.21. The firm has a 50 day moving average of $0.08 and a 200 day moving average of $0.69.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.